US$ 22.10
glp 1 drugs and parkinson's disease Glucagon-like peptide-1 (GLP-1) receptor agonists neuroinflammation: Implications for neurodegenerative treatment GLP-1 drug may help with
Description
3, July 2006, pp

This patient-centered approach enhances adherence, satisfaction, and outcomes

GLP1 receptor agonists effects beyond obesity and diabetes

Users are warned about thyroid cancer, pancreatitis, kidney problems, gallbladder disease, and allergic reactions

CSF and brain indices of insulin resistance, oxidative stress and neuro-inflammation in early versus late Alzheimers disease

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institutes Department of Science Education and the Robert Wood Johnson Foundation
